Rival to EpiPen Allergy Treatment to Return to Market

The maker of an EpiPen rival said its emergency allergy treatment would return to the market on Feb. 14, adding more competition to the market for the costly products.

from WSJ.com: US Business http://ift.tt/2jE5Usf
via IFTTT